Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share (VRNA)

145 filings reported holding VRNA - Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share as of Q2 2024.
Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share (VRNA) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 65.8M shares of 84.8M outstanding shares and own 77.63% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (7.63M shares), NEA Management Company, LLC (5.58M shares), Deep Track Capital, LP (4M shares), Vivo Capital, LLC (3.55M shares), Frazier Life Sciences Management, L.P. (3.31M shares), MAVERICK CAPITAL LTD (3.09M shares), ORBIMED ADVISORS LLC (2.86M shares), Carlyle Group Inc. (2.46M shares), PERCEPTIVE ADVISORS LLC (2.43M shares), and FEDERATED HERMES, INC. (2.16M shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.